Cellular Origins, an automated cell therapy manufacturing firm, will make Cambridge its global headquarters after signing a lease with Bruntwood SciTech to occupy a former AstraZeneca hub at Melbourn Science Park.
Bruntwood SciTech codes in major letting at Cambridge's Da Vinci
Cell therapy manufacturing group opening global headquarters
By Luke Haynes
CoStar NewsApril 16, 2026 | 1:25 P.M.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- Da Vinci Building
Melbourn Science Park, Melbourn, CAM
- Contacts
- Mark Leech
Mergers & Acquisitions Director, Bruntwood SciTech